pharma · Atopic Dermatitis Eczema · Plaque Psoriasis · ARQT
Arcutis Biotherapeutics
Arcutis Biotherapeutics clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 2945 Townsgate Rd, Westlake Village, California 91361, US
- Founded
- 2016
- Employees
- 427
- Programs
- 27
- Drugs
- 3
- Patents
- 30
Arcutis Biotherapeutics projects
9 ClinicalTrials.gov programs sponsored by Arcutis Biotherapeutics.
Arcutis Biotherapeutics has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ARQ-151 0.3% cream
Arcutis Biotherapeutics
Chronic Plaque Psoriasis
1 trial -
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
Arcutis Biotherapeutics
Atopic Dermatitis Eczema
1 trial -
Roflumilast 0.3% cream
Arcutis Biotherapeutics
Chronic Plaque Psoriasis
1 trial -
Roflumilast Cream
Arcutis Biotherapeutics
Atopic Dermatitis Eczema
1 trial -
Roflumilast Cream 0.05%
Arcutis Biotherapeutics
Atopic Dermatitis Eczema
1 trial -
Roflumilast Cream 0.15%
Arcutis Biotherapeutics
Atopic Dermatitis Eczema
1 trial -
Roflumilast Foam
Arcutis Biotherapeutics
Seborrheic Dermatitis
1 trial -
Roflumilast Foam 0.3%
Arcutis Biotherapeutics
Scalp Psoriasis
1 trial -
Topical roflumilast
Arcutis Biotherapeutics
Chronic Plaque Psoriasis
1 trial
Frequently asked questions
How many clinical projects does Arcutis Biotherapeutics have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.